Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Jazz Pharma Plc
(NQ:
JAZZ
)
114.24
+3.28 (+2.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Jazz Pharma Plc
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
3 Biotech Stocks That Could Be Millionaire Makers
November 22, 2023
Many biotech stocks offer exciting long-term growth prospects.
Via
The Motley Fool
Police Boss Turned Cannabis Reform Advocate, MMJ Legalization In Japan And More Global Updates
November 16, 2023
Medical Cannabis-Based Epidiolex Advances Through Japan's Legislature Earlier this week, Japanese policymakers gave the green light to a measure to legalize medical products derived from cannabis,...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
3 No-Brainer Stocks to Buy With $200 Right Now
November 15, 2023
A modest amount of money can go a long way when it's invested in inexpensive, game-changing businesses.
Via
The Motley Fool
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
November 09, 2023
Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.
Via
InvestorPlace
Jazz Pharmaceuticals: Q3 Earnings Insights
November 08, 2023
Via
Benzinga
Where Jazz Pharmaceuticals Stands With Analysts
September 29, 2023
Via
Benzinga
Expert Ratings for Jazz Pharmaceuticals
August 10, 2023
Via
Benzinga
Cannabis Cash Burn Concerns? Sell These 7 Overbought Stocks Now.
November 07, 2023
These overbought cannabis stocks are teetring on the edge as the sector is navigating through uncharted waters.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
FDA Report On Its 50 Years In Cannabis Research, Signals A Boost In Medical Marijuana Prospects
November 03, 2023
Researchers with the Food and Drug Administration (FDA) reported Wednesday on the agency’s 50 years of experience with marijuana research. In an article titled “FDA’s 50
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Product Safety
Ireland Reimburses Medical Marijuana-Based Drug For Chemotherapy-Induced Nausea And Vomiting
October 30, 2023
Althea Group Holdings Limited (ASX: AGH), an Australian manufacturer of cannabis-based medicines and recreational cannabis products confirmed that Ireland’s Primary Care Reimbursement...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Europe's High: UK Parents Need NHS Help For Daughter's Seizures, THC MMJ Flowers In Switzerland & More
October 24, 2023
Luxembourg: Medical Marijuana Shortage Due To Supplier Change
Via
Benzinga
Topics
Cannabis
Supply Chain
Exposures
Cannabis
Supply Chain
Cannabis Stocks Dip: How Rising Interest Rates Impact Your Portfolio
October 23, 2023
On Friday, cannabis stocks traded lower with the overall market. Marketfy analyst Michael Berger will be monitoring how the sector performs this week.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Europe's High: Irish GPs Against Pot, Switzerland-Spain Share Data On Cannabis Clubs & More
October 20, 2023
Denmark: Medical Marijuana Pilot Program Experience 90% Growth In 12 Months
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Jazz Pharmaceuticals Explores Asset Sale Option, Possibly Cannabinoid Business: Report
October 20, 2023
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) is reportedly exploring strategic options comprising a potential sale.
Via
Benzinga
2 Top Biotech Stocks to Buy in October
October 03, 2023
Growth catalysts lie ahead for both of these players.
Via
The Motley Fool
5 Genius Safe Stocks to Buy for the 4th Quarter of 2023
October 02, 2023
These highly profitable, time-tested companies can deliver for their shareholders in any economic climate.
Via
The Motley Fool
4 Perfect Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
September 30, 2023
An 18% decline in the Nasdaq Composite from its all-time high means bargains still abound.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Via
Benzinga
3 Cannabis Stocks That Should Be on Every Investor’s Radar This Fall
September 27, 2023
The cannabis industry is a quiet place where huge upside potential is building up. As more regions legalize, cannabis stocks can soar.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall
September 20, 2023
Even with higher for longer interest rates, drug discovery moves on. That’s why it’s still a good time to look for biotech stocks to buy.
Via
InvestorPlace
7 Cannabis Stocks to Buy BEFORE the Marijuana Rescheduling Boom
September 19, 2023
Cannabis stocks re seeing renewed interest and these seven look like reasonable buys as rescheduling approaches for weed.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
Cannabis Industry Changes As Marijuana Rescheduling Looms
September 15, 2023
As the Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the top...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
September 12, 2023
NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035.
Via
Benzinga
Prediction: These Could Be the Best-Performing Cannabis Stocks Through 2030
August 26, 2023
These two businesses may be sound, but generating returns in this industry has been tough, with no light at the end of the tunnel.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
Epidiolex Counterpart Debuts In Brazil's Cannabis Market As Its Maker Eyes TSX IPO
August 23, 2023
Verdemed, a pharmaceutical company known for producing cannabis-derived products, has received five fresh approvals from the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Jazz Pharmaceuticals' Neuroscience Pipeline Readouts In Focus: Analyst Lowers Price Target
August 14, 2023
Cantor Fitzgerald analyst Charles C.
Via
Benzinga
Jazz Pharmaceuticals Reports Q2 2023 Net Income Of $104.4M, What About Total Revenues?
August 09, 2023
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced its financial results for the second quarter of 2023, along with its outlook for the remainder of the year.
Via
Benzinga
3 Biotech Stocks You’ll Regret Not Buying Soon
August 08, 2023
These top biotech stocks are must-buys with huge potential, leading the industry with high-rewards for investors.
Via
InvestorPlace
Cannabis Stock Gainers And Losers From August 11, 2023
August 11, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
10 Health Care Stocks With Whale Alerts In Today's Session
August 08, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.